Vaccinex Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vaccinex inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vaccinex Inc Today - Breaking & Trending Today

AIGH Capital Management LLC Sells 273,112 Shares of Vaccinex, Inc. (NASDAQ:VCNX)

AIGH Capital Management LLC cut its stake in shares of Vaccinex, Inc. (NASDAQ:VCNX – Free Report) by 25.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 817,061 shares of the company’s stock after selling 273,112 shares during the period. AIGH Capital Management LLC owned about 0.07% of Vaccinex worth $543,000 as of its […] ....

Holdings Channel , Vaccinex Inc , Worth Venture Partners , Aigh Capital Management , Vaccinex Company Profile , Capital Management , Free Report , Venture Partners , Get Free Report , Visit Holdingschannel , Vaccinex Daily ,

Alnylam Pharmaceuticals (NASDAQ:ALNY) versus Vaccinex (NASDAQ:VCNX) Critical Contrast

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) and Vaccinex (NASDAQ:VCNX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends. Analyst Recommendations This is a summary of recent recommendations […] ....

United States , New York , United Kingdom , Emory University , Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Inc , Peptidream Inc , Huntington Study Group , Catalent Pharma Solutions , Biotech Co , Surface Oncology Inc , Vir Biotechnology Inc , Vaccinex Inc , Research Institute Inc , Dicerna Pharmaceuticals Inc , Regeneron Pharmaceuticals Inc , News Ratings For Alnylam Pharmaceuticals Daily , Ionis Pharmaceuticals Inc , H Lee Moffitt Cancer Center , Get Free Report , Given Alnylam Pharmaceutical , Regeneron Pharmaceuticals , Vir Biotechnology , Dicerna Pharmaceuticals , Ionis Pharmaceuticals , Merck Sharp ,